Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,485 | -10,539 | -3,075 | -24,688 | -19,261 |
| Depreciation Amortization | 43 | 27 | 10 | 38 | 24 |
| Other Working Capital | -1,013 | -1,004 | -860 | 1,814 | 1,061 |
| Other Operating Activity | 875 | 435 | -1,888 | 8,487 | 8,875 |
| Operating Cash Flow | $-14,580 | $-11,080 | $-5,813 | $-14,349 | $-9,301 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27 | -1 | N/A | -152 | -151 |
| Other Investing Activity | 0 | 0 | 0 | -35 | 0 |
| Investing Cash Flow | $-27 | $-1 | $N/A | $-186 | $-151 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -284 | -191 | -94 | -162 | -158 |
| Common Stock Issued | 32,841 | 30,491 | 18,485 | 15,711 | 15,711 |
| Other Financing Activity | 104 | 27 | 0 | 160 | 117 |
| Financing Cash Flow | $32,662 | $30,327 | $18,391 | $15,709 | $15,670 |
| Beginning Cash Position | 6,707 | 6,707 | 6,707 | 5,533 | 5,533 |
| End Cash Position | 24,762 | 25,952 | 19,285 | 6,707 | 11,751 |
| Net Cash Flow | $18,055 | $19,245 | $12,578 | $1,173 | $6,217 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,580 | -11,080 | -5,813 | -14,349 | -9,301 |
| Capital Expenditure | -27 | -1 | 0 | -152 | -151 |
| Free Cash Flow | -14,606 | -11,081 | -5,813 | -14,501 | -9,452 |